Akebia Therapeutics(DE:AX9)
€0.37+0.00 (+0.83%)
DE:AX9
Akebia Therapeutics earnings date
€0.37
At close:+0.00 (+0.83%)
Akebia Therapeutics (AX9) Q2 2025 Earnings Report
2 Followers
DE:AX9 Q2 2025 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.01
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.04
DE:AX9 Q2 2025 Revenue Results
- Actual Revenue
- EUR 56.68M
- Expected Revenue
- EUR 42.86M
- Beat/Miss
- Beat by +EUR 13.82M
- YoY Revenue Growth
- +43.13%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- Before Open
- Conference Call
- Thursday, August 7, 2025
DE:AX9 Upcoming Earnings
Akebia Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:AX9 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AX9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.06- | -0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.03-0.05 | 0 | ― | |
| Aug 05, 2026 | 2026 (Q2) | -0.04-0.03 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.03-0.03 | 0.03 | -200.00% (-0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.03-0.05 | -0.09 | 50.00% (+0.05) | |
| Nov 10, 2025 | 2025 (Q3) | -0.010.00 | -0.09 | 100.00% (+0.09) | |
| Aug 07, 2025 | 2025 (Q2) | -0.010.00 | -0.04 | 100.00% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.030.03 | -0.08 | 133.33% (+0.11) | |
| Mar 13, 2025 | 2024 (Q4) | -0.07-0.09 | 0 | ― | |
| Nov 07, 2024 | 2024 (Q3) | -0.06-0.09 | -0.07 | -25.00% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

